Physician profile
James Benz
NPI 1275544629
$2,076.68
in general payments reported to CMS, 2019-2025
13 companies · $887 in 2025
The $887 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $29.80 · 2021: $293 · 2022: $43.61 · 2023: $77.24 · 2024: $301 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $800 · Food and Beverage: $447 · Entertainment: $18.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $800.00 |
| Food and Beverage | $447.07 |
| Entertainment | $18.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $800.00 | 2025 | |
| Biohorizons Implant Systems INC. | $413.15 | 2019-2025 | Biohorizons Dental Implants |
| Patterson Companies, INC. | $168.20 | 2021 | |
| Straumann USA LLC | $162.22 | 2023-2024 | |
| Bisco, INC. | $152.65 | 2024 | |
| 3m Company | $96.49 | 2019 | |
| Zimmer Biomet Holdings, INC. | $61.84 | 2019 | |
| Solventum Corporation | $56.18 | 2024-2025 | 3m Clinpro, 3m Relyx |
| Nobel Biocare USA | $53.15 | 2019 | |
| Salvin Dental Specialties, INC. | $43.19 | 2021 | |
| Envista Holdings Corporation | $36.90 | 2024 | K3 |
| Dentsply Sirona INC | $20.83 | 2019 | |
| Ultradent Products INC | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Benz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.